Biotechnology

Venue: Merinos Ataturk Congress Culture Centre - Immigration History Museum/ Bursa

Date and Time: 26 January 2016/ 15.00 – 16.00

Speaker: Professor Mark Smales

The British Council’s fifth "Science For All Talks" series tooke place on 26 January 2016 at Bursa Merinos Ataturk Congress Culture Centre.

The talk focused on the impact of biotechnology on health, agriculture and industry.It will be delivered by Professor Mark Smales from the University of Kent. Mark Smales is Professor of Industrial Biotechnology at the School of Biosciences and Programme Director for MSc in Biotechnology and Bioengineering at the University of Kent. Professor Smales’ research focuses on understanding biotechnological products and processes.

The talk will also be broadcasted in the following months on Sky Turk 360 TV channel’s “Do you Have an Idea?” programme.

The talk was free and open to public. 

QUESTIONS ON TWITTER AND FACEBOOK

Among the participants who asked questions on Facebook and Twitter with the hashtag #herkesicinbilim, 10 people won our Science for All mug. You can see the full list of winners below. We kindly ask the winners to send an email to Customer.Services@britishcouncil.org.tr with ''Biotechnology competition"  in the subject line, and provide their contact details, including their phone number and postal address. Please send your email latest by 8 February 2016, Monday.

  • Canan Var
  • Mehtap Ölçen
  • Perihan Kobakcam
  • Meral Şahankaya
  • Sedat Korkmaz
  • Necmiye Akgüller
  • Dilek Doğan
  • Kara Kenan
  • Funda Doğan
  • Figen Onuksoy Çalışkan

 

ABOUT THE SPEAKER

Mark Smales is currently Professor of Industrial Biotechnology and the Director of the Centre for Molecular Processing at the University of Kent, Canterbury, UK. He completed his training at Massey University in New Zealand from where he obtained his PhD. After a period of postdoctoral training he was appointed to a lectureship at the University of Kent. His research is focussed around production and design of protein based biopharmaceutical drugs for use in the clinic and addressing challenges associated with the synthesis of such high value biopharmaceutical proteins (e.g. monoclonal antibodies, various fusion proteins) from cultured mammalian cells. The work in his laboratory is recognised as world leading in this field. A number of the research findings from his laboratory have been followed up by industry to translate the ideas and findings into applications to improve the production of these expensive biotherapeutic proteins. He is an Executive Editor of Biotechnology Letters and on the board of Biotechnology and Applied Biochemistry. Prof Smales was a member of the BBSRC/EPSRC Bioprocessing Research Industrial Club (BRIC) steering committee for 5 years and currently director of the BioProcessing Network in the UK. He has been asked to give multiple keynote presentations in the area of his research at international conferences, industrial workplaces, schools and engaged with the wider community through various outreach activities.

----------------------------------------

The British Council is committed to a policy of equal opportunity and welcomes people from all sections of the community.

Share this